Haisco Pharmaceutical Group: Announcement Regarding Obtaining the Drug Clinical Trial Approval Notice for Innovative Drug HSK44459 Tablets

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.